Physician profile
Cynthia Rector
NPI 1942276829
$4,108.77
in general payments reported to CMS, 2019-2025
18 companies · $995 in 2025
The $995 reported for 2025 was more than what 81% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $98.26 · 2021: $142 · 2022: $959 · 2023: $570 · 2024: $956 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,521.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $591.82 | 2022-2025 | Spravato, Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $545.35 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $471.16 | 2019-2025 | Rexulti, Nuedexta |
| Abbvie INC. | $372.73 | 2021-2024 | |
| Alkermes, INC. | $343.80 | 2019-2025 | Vivitrol, Vivitrol |
| Indivior INC. | $266.07 | 2022-2025 | Sublocade |
| Neurocrine Biosciences, INC. | $252.28 | 2022-2024 | Ingrezza |
| Vanda Pharmaceuticals INC. | $238.52 | 2019-2025 | Fanapt |
| Acadia Pharmaceuticals INC | $221.71 | 2019-2022 | |
| Braeburn INC. | $172.38 | 2023-2025 | Brixadi |
| E.R. Squibb & Sons, L.L.C. | $148.17 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $139.56 | 2022-2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $103.00 | 2025 | Austedo Xr |
| Avanir Pharmaceuticals, INC. | $102.50 | 2022 | |
| Sunovion Pharmaceuticals INC. | $87.12 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $24.31 | 2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $15.80 | 2022 | |
| Allergan, INC. | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Rector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.